Jameson Resources Limited (JAL.AX)
AUD 0.05
(0.0%)
AUD 0.05
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | - | 5065.00 | 559.00 | 35.14 Thousand | 46.85 Thousand | 21.28 Thousand |
| Cost of Revenue | 2894.00 | 3405.00 | 3230.00 | 4042.00 | 5029.00 | 5086.00 |
| Gross Profit | -2894.00 | 1660.00 | -2671.00 | 31.1 Thousand | 41.82 Thousand | 16.2 Thousand |
| Operating Expenses | 1.23 Million | 1.9 Million | 1.03 Million | 986.6 Thousand | 1.25 Million | 1.24 Million |
| Selling, General and Administrative Expenses | 1.23 Million | 636.44 Thousand | 630.93 Thousand | 561.19 Thousand | 795.79 Thousand | 1.24 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 35.96 Thousand | 122.73 Thousand | 30.87 Thousand | 46.05 Thousand | 48.23 Thousand |
| Cost and Expenses | 1.24 Million | -1.87 Million | -909.56 Thousand | -990.86 Thousand | -1.24 Million | 1.24 Million |
| Operating Income | -1.24 Million | -1.9 Million | -1.03 Million | -951.45 Thousand | -1.22 Million | -1.24 Million |
| Interest Expense | - | - | - | - | 9731.00 | 10.22 Thousand |
| Income Tax Expense | -208.69 Thousand | -61.31 Thousand | -48.36 Thousand | -63.61 Thousand | -1.61 Million | -131.25 Thousand |
| Earnings before Tax | -1.34 Million | -1.87 Million | -909 Thousand | -955.72 Thousand | -1.19 Million | -1.25 Million |
| Net Income | -1.24 Million | -1.81 Million | -860.64 Thousand | -841.4 Thousand | 105.1 Thousand | -1.13 Million |
| Earnings Per Share Basic | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 | -0.00 |
| Earnings Per Share Diluted | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 | -0.00 |
| Weighted Average Shares Outstanding | 417.76 Million | 376.56 Million | 329.47 Million | 300.51 Million | 263.29 Million | 263.29 Million |
| Weighted Average Shares Outstanding (Diluted) | 417.76 Million | 376.56 Million | 329.47 Million | 300.51 Million | 263.29 Million | 263.29 Million |
| Gross Margin | - | 0.33 | -4.78 | 0.88 | 0.89 | 0.76 |
| EBIT Margin | - | -375.93 | -1839.92 | -27.96 | -25.29 | -58.40 |
| Profit Margin | - | -357.39 | -1539.61 | -23.94 | 2.24 | -53.23 |
| EBITDA | -1.34 Million | -1.86 Million | -905.77 Thousand | -951.68 Thousand | -1.19 Million | -1.25 Million |
| Earnings Before Tax Margin | - | -375.60 | -1844.70 | -27.07 | -26.07 | -58.64 |
| Breakdown | 2024 Q4 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | 2226.00 | 2226.00 | 5065.00 | 1897.00 | 1897.00 |
| Cost of Revenue | 1429.00 | 1465.00 | - | 3405.00 | 1749.00 | - |
| Gross Profit | -1429.00 | 761.00 | 2226.00 | 1660.00 | 148.00 | 1897.00 |
| Operating Expenses | 643.84 Thousand | 332.52 Thousand | 332.52 Thousand | 1.9 Million | 1.19 Million | 560.35 Thousand |
| Selling, General and Administrative Expenses | 643.84 Thousand | 297.93 Thousand | 297.93 Thousand | - | 1.19 Million | 596.7 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | 35.96 Thousand | - | - |
| Cost and Expenses | 645.27 Thousand | 332.52 Thousand | 332.52 Thousand | -1.87 Million | 1.19 Million | 560.35 Thousand |
| Operating Income | -645.27 Thousand | -296.44 Thousand | -296.44 Thousand | -1.9 Million | -1.19 Million | -595.68 Thousand |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -111.26 Thousand | -34.15 Thousand | -17.08 Thousand | -61.31 Thousand | -12.78 Thousand | -12.78 Thousand |
| Earnings before Tax | -688.65 Thousand | -330.3 Thousand | -330.3 Thousand | -1.87 Million | -1.11 Million | -558.45 Thousand |
| Net Income | -620.76 Thousand | -313.22 Thousand | -313.22 Thousand | -1.81 Million | -1.09 Million | -545.67 Thousand |
| Earnings Per Share Basic | -0.00 | -0.00 | -0.00 | - | -0.00 | -0.00 |
| Earnings Per Share Diluted | -0.00 | -0.00 | -0.00 | - | -0.00 | -0.00 |
| Weighted Average Shares Outstanding | 489.06 Million | 313.22 Million | 313.22 Million | 376.56 Million | 391.51 Million | 393.7 Million |
| Weighted Average Shares Outstanding (Diluted) | 489.06 Million | 313.22 Million | 313.22 Million | 376.56 Million | 391.51 Million | 393.69 Million |
| Gross Margin | - | 0.34 | 1.00 | 0.33 | 0.08 | 1.00 |
| EBIT Margin | - | -132.84 | -132.84 | - | -629.10 | -313.55 |
| Profit Margin | - | -140.71 | -140.71 | -357.39 | -575.30 | -287.65 |
| EBITDA | -687.22 Thousand | -295.71 Thousand | -295.71 Thousand | - | -1.19 Million | -594.81 Thousand |
| Earnings Before Tax Margin | - | -133.17 | -133.17 | -375.60 | -630.03 | -314.01 |
MEDICAMEQ
OGN
OVCHY
8159
FEVR
SURFI